Project Grant HT94252410772
Award Date
8/1/24
Completion Date
7/31/27
Dollars Obligated
$757K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
William Penn Annex West, PA 19107, USA
Similar Awards
This federal Project Grant award of $858,000.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports a longitudinal analysis of the mesenchymal cell state from melanoma initiation to metastatic progression at Thomas Jefferson University's Sidney Kimmel Medical College. The award, effective August 1, 2024, with a completion date of July 31, 2027, funds advanced biomedical research aimed at transforming healthcare for...
The Defense Health Agency awarded a $312,000 Project Grant to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, to conduct research on "Inhibiting Mitochondrial Permeability Transition Pore Opening to Treat Mitochondrial Myopathy" over the period of September 1, 2023 to August 31, 2025. This grant was provided through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to...
The Department of the Army Medical Command awarded Thomas Jefferson University a $841,473 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop occult colorectal cancer elimination through GUCY2C-directed immunotherapy. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
This federal Project Grant award of $429,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by Thomas Jefferson University, doing business as Sidney Kimmel Medical College, to develop a measles-vectored cytomegalovirus vaccine that induces neutralizing and non-neutralizing antibodies. The award period runs from January 1, 2025 to December 31, 2026. As a leading research institution, Thomas Jefferson University...
Thomas Jefferson University will receive $3,052,929 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to research occult colorectal cancer elimination by GUCY2C-directed immunotherapy from July 1, 2022 to June 30, 2026. Specifically, the Sidney Kimmel Medical College of Thomas Jefferson University will investigate medical solutions for the battlefield and transform healthcare for service members and the public through...
The Department of the Army Medical Command awarded a $802,843 Project Grant to Thomas Jefferson University under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2021 through May 31, 2025. The grant funds a precision medicine research project utilizing patient-derived xenograft models of serous ovarian cancer to investigate methyl CpG binding protein 2 (MECP2) overexpression as a potential biomarker and dependency. Researchers will screen tissue...
Thomas Jefferson University, doing business as Sidney Kimmel Medical College, was awarded a $234,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year grant will fund research into precision therapies for metastatic uveal melanoma prevention and treatment by investigating multimodal GNAQ signaling pathways. Through September 2021 to August 2024, Sidney Kimmel Medical College researchers will work to transform...
The U.S. Department of Defense's Defense Health Agency awarded a $780,000 Project Grant to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, for a 3-year research project titled "DEGRADATION OF MUTANT GNAQ 11 IN UVEAL MELANOMA CELLS". The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research related to military medicine, including cancer, neurological disorders, and other conditions...
The Defense Health Agency awarded Thomas Jefferson University a $779,200 project grant under the Military Medical Research and Development program (CFDA 12.420) to conduct senotherapy research for amyotrophic lateral sclerosis (ALS) from April 1, 2023 through March 31, 2025. The grant will support basic, applied, and advanced biomedical research investigating medical solutions for ALS, consistent with the program's goals of transforming military and public health care through innovative...
This Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $725,001.00 to Thomas Jefferson University - Sidney Kimmel Medical College to conduct research aimed at "Improving Wound Healing and Recovery by Blocking Excessive Scar Formation in Peripheral Nerves, Muscles, and Joints After Composite Injuries to Extremities." The research, which will take place in Philadelphia, PA, is intended to transform healthcare for service...